P. Dodion
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Otorhinolaryngology top 5%
Papers in
- Oncology 41
- Cancer Treatment and Pharmacology 25
- HER2/EGFR in Cancer Research 5
-
- Cancer therapeutics and mechanisms 14
- Biochemical and Molecular Research 5
- Co-authors
- Marcel Rozencweig (22 shared papers)Frank G. Haluska (5 shared papers)M. Clavel (5 shared papers)J. Renard (5 shared papers)Herbert M. Pinedo (4 shared papers)S. Gundersen (3 shared papers)U. Bruntsch (4 shared papers)M. van Glabbeke (3 shared papers)
- Journals
- Annals of Oncology (5 papers)Investigational New Drugs (4 papers)Journal of Clinical Oncology (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)Cancer (3 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
P. Dodion
74 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Oncology 424
- Otorhinolaryngology 61
- Obstetrics and Gynecology 90
- Reproductive Medicine 76
- Cancer Research 103
Countries citing papers authored by P. Dodion
This map shows the geographic impact of P. Dodion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Dodion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Dodion more than expected).
Fields of papers citing papers by P. Dodion
This network shows the impact of papers produced by P. Dodion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Dodion. The network helps show where P. Dodion may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Dodion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 103 | |
| 2 | 2013 | 94 | |
| 3 | 2015 | 92 | |
| 4 | 2011 | 68 | |
| 5 | 1982 | 50 | |
| 6 | 1987 | 37 | |
| 7 | 1990 | 36 | |
| 8 | Doxorubicin and cisplatin excretion into human milk. | 1985 | 36 |
| 9 | 1990 | 34 | |
| 10 | 2012 | 33 | |
| 11 | 2014 | 30 | |
| 12 | 1990 | 29 | |
| 13 | 1986 | 28 | |
| 14 | 1990 | 24 | |
| 15 | 1982 | 24 | |
| 16 | 1988 | 23 | |
| 17 | 1986 | 22 | |
| 18 | 1984 | 22 | |
| 19 | 1984 | 22 | |
| 20 | 1988 | 20 |
About P. Dodion
P. Dodion is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Infectious Diseases, having authored 75 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (25 papers), Cancer therapeutics and mechanisms (14 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Chemotherapy-related skin toxicity (6 papers), HER2/EGFR in Cancer Research (5 papers), Biochemical and Molecular Research (5 papers), Head and Neck Cancer Studies (5 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Oncology (424 citations), Otorhinolaryngology (61 citations), Obstetrics and Gynecology (90 citations), Reproductive Medicine (76 citations) and Cancer Research (103 citations). P. Dodion has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Marcel Rozencweig, Frank G. Haluska, M. Clavel, J. Renard, Herbert M. Pinedo, S. Gundersen, U. Bruntsch, M. van Glabbeke, R Abele and Y. Kenis. Their work appears in journals such as Annals of Oncology, Investigational New Drugs, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.